Overview

A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the clinical activity of sunitinib in patients with advanced thymic carcinoma who have failed chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
SMG-SNU Boramae Medical Center
Treatments:
Sunitinib